Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-22
2008-07-22
Andres, Janet L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C544S363000, C546S153000
Reexamination Certificate
active
07402583
ABSTRACT:
The invention provides a compound of Formula (Ia),or a pharmaceutically acceptable salt thereof, a process for t he preparation of a compound of Formula (1a) and pharmaceutical compositions of a compound of Formula (1a).
REFERENCES:
patent: 3936461 (1976-02-01), Schwender et al.
patent: 4421920 (1983-12-01), Baudouin et al.
patent: 5215999 (1993-06-01), Uchida et al.
patent: 5409930 (1995-04-01), Spada et al.
patent: 5650415 (1997-07-01), Tang et al.
patent: 5656643 (1997-08-01), Spada et al.
patent: RE36256 (1999-07-01), Spada et al.
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6521618 (2003-02-01), Boschelli et al.
patent: 6630489 (2003-10-01), Crawley
patent: 6638945 (2003-10-01), Gibson
patent: 0 326 330 (1989-08-01), None
patent: 2 077 455 (1971-10-01), None
patent: 93/03030 (1993-02-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 97/17329 (1997-05-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/43960 (1998-10-01), None
patent: WO9843960 (1998-10-01), None
patent: WO 99/01421 (1999-01-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 00/18740 (2000-04-01), None
patent: WO 00/18761 (2000-04-01), None
patent: WO 00/68199 (2000-11-01), None
patent: WO 00/68200 (2000-11-01), None
patent: WO 00/68201 (2000-11-01), None
patent: WO 02/36570 (2002-05-01), None
patent: WO 03/008409 (2003-01-01), None
patent: WO 2004/005284 (2004-01-01), None
Ca 137:190369, “Hair dyes containing cationic quinolinium direct dyes”, Wella A.G., DE 20204129, Aug. 29, 2002.
Ca 89:117684, “Hydroxyethylnicotinamide vector for therapeutically active acids”, Cousse et. al., Travaux de la Societe de Pharmacie de Montpellier, 1978, 38 (1), 71-6.
Boyle Francis Thomas
Foote Kevin Michael
Gibson Keith Hopkinson
Andres Janet L.
AstrZenca AB
Morgan & Lewis & Bockius, LLP
Robinson Binta
LandOfFree
Substituted quinolines as antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinolines as antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolines as antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2806947